Clinical Impact of CDK4/6 Inhibitors in De Novo or PR- or Very Elderly Post-Menopausal ER+/HER2- Advanced Breast Cancers.

Saved in:
Bibliographic Details
Title: Clinical Impact of CDK4/6 Inhibitors in De Novo or PR- or Very Elderly Post-Menopausal ER+/HER2- Advanced Breast Cancers.
Authors: Tang H; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Yeo D; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., De Souza K; Department of Oncology, University College London Hospitals NHS Foundation Trust, London NW1 2PG, UK., Ahmad O; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Shafiq T; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Ofor O; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Anand A; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Karim S; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Khan S; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK., Madhusudan S; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.; Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Source: Cancers [Cancers (Basel)] 2023 Oct 26; Vol. 15 (21). Date of Electronic Publication: 2023 Oct 26.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers15215164